RadSense
Radial Artery Hemostasis Device
Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Company Overview
Snapshot
Founded in May 2016 by Ran Kornowski and Roni Talic, RadSense operates with 1–10 employees. The company is in the Pre-Funding stage and holds one patent. RadSense ceased operations in May 2022.
Business overview
RadSense is a Health Tech & Life Sciences company focused on developing medical devices. Its core product is a device designed to apply pressure to the radial artery to prevent bleeding while maintaining blood flow. The company operates within the Medical Devices sector, specifically targeting Medical Treatment & Therapeutics, and serves the Healthcare market, including providers.
Log in to access full profile ›Company Intelligence Q&A
- What is RadSense's primary focus?
- RadSense is developing a medical device for radial artery hemostasis, designed to prevent bleeding while ensuring continued blood flow through the artery.
- When was RadSense founded?
- RadSense was founded in May 2016.
- Who are the founders of RadSense?
- RadSense was founded by Ran Kornowski and Roni Talic.
- In which sector does RadSense primarily operate?
- RadSense operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
- What is the current status of RadSense?
- RadSense is currently non-active and ceased to operate in May 2022.